Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in hospitalized patients with type 2 diabetes mellitus and COVID-19
2020-001929-31Phase 4Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronavirus disease 2019 (COVID-19) and type 2 diabetes mellitus (T2DM) comparing Pioglitazone + standard of care with Standard of care alone (2 arms). Primary endpoint: Outcome of hospitalization. Started Jul 2020; status: active.
02
Drugs
pioglitazone
03
Conditions
coronavirus disease 2019 (COVID-19)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2020-001929-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001929-31.